www.qiagen.com Open in urlscan Pro
2620:1ec:4f:1::45  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Check your dPCR experimentSee how we can support you online during COVID-19
 * Products
 * Applications & Insights
 * Knowledge & Support
 * About QIAGEN
   

   
 * Quick Order
   
 * 0 Cart
 * My QIAGEN
   



 * Plan your experiment
   
   
 * Discovery & Translational Research
   
   
 * Diagnostics & Clinical Research
   
   
 * Human ID & Forensics
   
   
 * Next-Generation Sequencing
   
   
 * Instruments & Automation
   
   
 * Informatics & Data
   
   
 * OEM by QIAGEN
   
   
 * COVID-19
   
   
 * Top Sellers
   
   
 * New Solutions
   
   
 * Shop
   
   
   




Enzymes for molecular biology

Explore high-quality enzymes; now available as individual products.



Products and tools for your targets

Explore targets and pathways in their scientific context, find and customize
products to study them, analyze data and plan follow-up studies – all in
GeneGlobe.



QuantiFERON-TB Gold Plus

Detect TB infection with confidence.




Looking for a quick way to design experiments?
Try the Workflow Configurator. A convenient tool to build experimental workflows
and find products to match your needs.
Welcome to My QIAGEN
Dashboard
Account
Orders
Log Out



WELCOME TO QIAGEN!

You can accept or revoke the cookies used on this website at any time with the
selection below or by adjusting your cookie settings. For complete details about
our cookies, see our Cookie Policy.
Customize Only necessary Accept all
Syndromic testing


THE FUTURE OF INFECTIOUS DISEASE DIAGNOSTICS


 1. Home
 2. Applications & Insights
 3. Syndromic Testing


DISCOVER - RAPID SYNDROMIC TESTING

 * Benefits
 * Workflow
 * Products
 * Events

GET THE RIGHT DIAGNOSIS THE FIRST TIME




Patients with infectious illnesses often have signs and symptoms that are
indicative of a disease, but that isn't specific enough to clinically
distinguish what makes them ill. These patients are frequently given broad
treatment, heavy monitoring and possibly unnecessary interventions. This puts a
burden on healthcare systems, clinical labs and clinicians, and means patients
aren't getting the best care possible.

We’re committed to helping healthcare workers like you navigate the challenges
of diagnosing infectious diseases. That’s why we’ve developed an easy-to-use,
automated diagnostic testing system that can help eliminate the guesswork and
make your job easier. Our tests use multiplex PCR technology – also known as
syndromic testing – that can quickly survey many different pathogens in a single
patient sample. With syndromic testing, you get the answers you need, when you
need them. And your patients get better care, faster.

Enhance your mpox research with the QIAstat-Dx Viral Vesicular Panel

LEARN MORE
LATEST INSIGHTS
–
WEBINARS, STORIES AND MORE

HEALTHCARE PROVIDERS – THIS ONE’S FOR YOU

Explore dedicated resources for healthcare providers and learn how we can help
you take the guesswork out of your diagnostics.

See resources

LIFT THE VEIL ON INFECTIOUS DISEASES AT ECCMID 2023

We’re excited to show you the daring new molecular tools that will transform how
you diagnose infectious diseases. See everything we have to offer this year at
booth C3-03.

Explore ECCMID 2023

YOUR PEERS ARE SWITCHING TO RAPID DIAGNOSTICS – WILL YOU?

Setting up a new rapid diagnostic test in your hospital doesn’t need to just be
a dream. Explore 3 factors you’ll need to take into consideration to set your
team up for success.

Get top tips

ANTIMICROBIAL RESISTANCE AND THE ROLE OF DIAGNOSTIC STEWARDSHIP

Global antimicrobial resistance, particularly in respiratory infections, is
growing. Fortunately, diagnostic stewardship can be instrumental in fighting
this ongoing threat. Read the article to learn more.

Read the article

WHERE SURFING AND SYNDROMIC TESTING COLLIDE

Learn how syndromic testing and surfing are two parts of Dr. Danilo Buonsenso’s
approach to holistic health for his most vulnerable patients.

Read his story

YOUR LAB IN THE PALM OF YOUR HAND 

What if you could monitor your diagnostic testing status anytime, anywhere? And
get around-the-clock proactive technical support? It’s possible with QIAstat-Dx
connectivity, powered by QIAsphere.*

DISCOVER QIASPHERE

New to rapid diagnostics with syndromic testing?
Find the information you need and learn how to incorporate syndromic testing
into your diagnostic strategy.
LEARN MORE
VOICES FROM THE FIELD
–
HOW MEDICAL PROFESSIONALS ARE USING SYNDROMIC DIAGNOSTICS

“It changed our perception, our prescription habits, and it will change the way
we work in the future. In the end, we gain money for both the community and the
patients. That is really a big step forward.”

Celestin Alexis Agbessi, M.D., Bichat-Claude Bernard Hospital, Paris

“It’s hugely beneficial to be able to test for that wide range of pathogens.
Ruling out COVID is helpful, but so is the chance to correctly identify other
illnesses so physicians can treat the patients and their symptoms
appropriately.”

Michelle Volk, CEO and president of Great Lakes Labs, Indiana, USA

“Our value to our patients and to our provider community has increased by
bringing the QIAstat-Dx in-house.”

Joshua Arant, Founder and Chief Operations Officer, Mako Medical


TELL US ABOUT YOURSELF


HELP US PROVIDE MORE OF THE CONTENT THAT YOU'RE LOOKING FOR BY SELECTING TOPICS
THAT INTEREST YOU.


TELL US ABOUT YOURSELF

 Academic Research
 Applied testing/Forensics
 Bioinformatics
 Biomedical Research
 Molecular/Clinical Diagnostics
 Pharma/Biotech

Already have a My QIAGEN account? Sign in to see your saved interests
FEATURED
–
RESOURCES FOR INFECTIOUS DISEASE DIAGNOSTICS

A SIMPLE SYNDROMIC WORKFLOW

See how quick and intuitive syndromic testing can be. Use this interactive demo
to try out the QIAstat-Dx Analyzer for yourself.

TRY AN INTERACTIVE DEMO

EXPLORE OUR LIBRARY OF WEBINARS

Watch our most recent webinars to learn how experts have incorporated syndromic
testing into their diagnostic approach. Plus, get the latest insights on
molecular diagnostics for infectious diseases.

WATCH WEBINARS

DIVE INTO ARTICLES

Get the latest information on syndromic testing for infectious diseases,
including insights on new publications and developments.

READ ARTICLES
Have a question about multiplex panel testing?
Get in touch with us today.
Contact us

REFERENCES

 1. Yalamanchili H, et al. (2018) Gastroenterol Hepatol, 14(11):646-652
 2. Binnicker M. Multiplex. (2015) J. Clin Microbiology, 53(12):3723-3728
 3. Macfarlane-Smith L, et al. (2018) Gastrointestinal Infections, 34(1):19-2
 4. Echavarria M, et al. (2018) J Clin Virol, 108:90–95
 5. Beal S G, et al. (2018) J Clin Microbiol, 18;56(1)
 6. Bouzid D, et al. (2020) J Hospital Infection, 337-338
 7. Iroh Tam PY, et al. (2017) Children (Basel), 4(1)
 8. Zhu et al. (2018) Clin Pediatr, 58(2): 185-190
 9. Martinez RM, et al. (2016) Clinical Virology Symposium, Poster #C-368

*Some features require a QIAstat-Dx Connectivity plan. Flexible plans are
available to meet your lab’s needs.

Product claims may differ from country to country based on regulations and
approvals. Contact your country representative for further details.

The QIAstat-Dx Viral Vesicular Panel is for research use only. The QIAstat-Dx
Viral Vesicular Panel is run on the QIAstat-Dx Analyzer.

The QIAstat-Dx Analyzer is intended for in vitro diagnostic use.

The QIAstat-Dx Respiratory SARS-CoV-2 Panel is intended for in vitro diagnostic
use.

 * This product has not been FDA cleared or approved, but has been authorized
   for emergency use by FDA under an EUA for use by authorized laboratories;
 * This product has been authorized only for the detection and differentiation
   of nucleic acid of SARS-CoV-2 from multiple respiratory viral and bacterial
   organisms; and
 * This emergency use of this product is only authorized for the duration of the
   declaration that circumstances exist justifying the authorization of
   emergency use of in vitro diagnostics for detection and/or diagnosis of
   COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act,
   21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or
   authorization is revoked sooner
   






COUNTRY AND LANGUAGE

Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica
Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas
Bahrain Bangladesh Barbados Belgium Belize Benin Bermuda Bhutan Bolivia
(Plurinational State of) Bosnia and Herzegovina Botswana Bouvet Island Brazil
British Indian Ocean Territory British Virgin Islands Brunei Darussalam (Brunei)
Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands
Central African Republic Chad Chile China Christmas Island Cocos (Keeling)
Islands Colombia Comoros Congo Cook Islands Costa Rica Croatia Cyprus Czech
Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican
Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia
Falkland Islands (Malvinas) Faroe Islands Federated States of Micronesia Fiji
Finland France French Guiana French Polynesia French Southern Territories Gabon
Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam
Guatemala Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands
Honduras Hong Kong Hungary Iceland India Indonesia Iraq Ireland Israel Italy
Ivory Coast Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao
People's Democratic Republic Latvia Lebanon Lesotho Liberia Libia Liechtenstein
Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta
Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Moldova Monaco
Mongolia Montserrat Morocco Mozambique Myanmar (Burma) Namibia Nauru Nepal
Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger
Nigeria Niue North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau
Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Islands Poland
Portugal Puerto Rico Qatar Reunion Romania Rwanda Saint Helena, Ascension and
Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon
Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi
Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia
Solomon Islands Somalia South Africa South Georgia and the South Sandwich
Islands South Korea Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen
Swaziland Sweden Switzerland Taiwan Tajikistan Tanzania Thailand Togo Tokelau
Tonga TP Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos
Islands Tuvalu U.S. Virgin Islands Uganda Ukraine United Arab Emirates United
Kingdom United States Minor Outlying Islands United States of America Uruguay
Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wallis and Futuna Western
Sahara Yemen Zambia Zimbabwe
Select Language English Chinese (Simplified, PRC) French German Japanese (Japan)
Korean (Korea) Spanish


FOLLOW US

 * 
 * 
 * 
 * 
 * 
   


CONTACT US

 * 
 * 
   

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of
Service apply.

Sample to Insight
© QIAGEN 2013–23. All rights reserved
Trademarks & DisclaimersTerms & ConditionsPrivacyConsent
ManagerAccessibilityCancellation and Returns

Healthcare providers – this one’s for you
Explore dedicated resources for healthcare providers and learn how we can help
you take the guesswork out of your diagnostics.
See resources
Lift the veil on infectious diseases at ECCMID 2023
We’re excited to show you the daring new molecular tools that will transform how
you diagnose infectious diseases. See everything we have to offer this year at
booth C3-03.
Explore ECCMID 2023
Your peers are switching to rapid diagnostics – will you?
Setting up a new rapid diagnostic test in your hospital doesn’t need to just be
a dream. Explore 3 factors you’ll need to take into consideration to set your
team up for success.
Get top tips
Antimicrobial resistance and the role of diagnostic stewardship
Global antimicrobial resistance, particularly in respiratory infections, is
growing. Fortunately, diagnostic stewardship can be instrumental in fighting
this ongoing threat. Read the article to learn more.
Read the article
Where surfing and syndromic testing collide
Learn how syndromic testing and surfing are two parts of Dr. Danilo Buonsenso’s
approach to holistic health for his most vulnerable patients.
Read his story
A simple syndromic workflow
See how quick and intuitive syndromic testing can be. Use this interactive demo
to try out the QIAstat-Dx Analyzer for yourself.
TRY AN INTERACTIVE DEMO
Explore our library of webinars
Watch our most recent webinars to learn how experts have incorporated syndromic
testing into their diagnostic approach. Plus, get the latest insights on
molecular diagnostics for infectious diseases.
WATCH WEBINARS
Dive into articles
Get the latest information on syndromic testing for infectious diseases,
including insights on new publications and developments.
READ ARTICLES